Literature DB >> 22210808

Pulmonary hypertension in patients with sickle cell disease: not so frequent but so different.

G Simonneau, F Parent.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 22210808     DOI: 10.1183/09031936.00119811

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  7 in total

1.  Prostacyclin-analog therapy in sickle cell pulmonary hypertension.

Authors:  Nargues A Weir; Rehan Saiyed; Shoaib Alam; Anna Conrey; Himanshu D Desai; M Patricia George; Jennifer H Keeley; Elizabeth S Klings; Alem Mehari; James G Taylor; Caterina P Minniti; Gregory J Kato
Journal:  Haematologica       Date:  2017-01-25       Impact factor: 9.941

2.  Chronic transfusion therapy improves but does not normalize systemic and pulmonary vasculopathy in sickle cell disease.

Authors:  Jon A Detterich; Roberta M Kato; Miklos Rabai; Herbert J Meiselman; Thomas D Coates; John C Wood
Journal:  Blood       Date:  2015-06-02       Impact factor: 22.113

3.  Hemodynamic predictors of mortality in adults with sickle cell disease.

Authors:  Alem Mehari; Shoaib Alam; Xin Tian; Michael J Cuttica; Christopher F Barnett; George Miles; Dihua Xu; Catherine Seamon; Patricia Adams-Graves; Oswaldo L Castro; Caterina P Minniti; Vandana Sachdev; James G Taylor; Gregory J Kato; Roberto F Machado
Journal:  Am J Respir Crit Care Med       Date:  2013-04-15       Impact factor: 21.405

4.  Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom.

Authors:  Mark T Gladwin; Robyn J Barst; J Simon R Gibbs; Mariana Hildesheim; Vandana Sachdev; Mehdi Nouraie; Kathryn L Hassell; Jane A Little; Dean E Schraufnagel; Lakshmanan Krishnamurti; Enrico Novelli; Reda E Girgis; Claudia R Morris; Erika Berman Rosenzweig; David B Badesch; Sophie Lanzkron; Oswaldo L Castro; James G Taylor; Jonathan C Goldsmith; Gregory J Kato; Victor R Gordeuk; Roberto F Machado
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

5.  The role of phosphodiesterase inhibitors in the management of pulmonary vascular diseases.

Authors:  Ghazwan Butrous
Journal:  Glob Cardiol Sci Pract       Date:  2014-10-16

6.  Pulmonary hypertension in Nigerian adults with sickle cell anemia.

Authors:  Valentine N Amadi; Michael O Balogun; Norah O Akinola; Rasaaq A Adebayo; Anthony O Akintomide
Journal:  Vasc Health Risk Manag       Date:  2017-05-08

Review 7.  Biomarkers and recent advances in the management and therapy of sickle cell disease.

Authors:  Marilyn J Telen
Journal:  F1000Res       Date:  2015-10-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.